Pharmaceuticals

TIBET AIM PHARM

TIBET AIM PHARM released FY2026 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 182.58 M, actual EPS CNY 0.11

TIBET AIM PHARM released FY2025 earnings on April 27 After-Market (BJT), actual revenue CNY 636.27 M, actual EPS CNY 0.5

TIBET AIM PHARM released FY2025 Q4 earnings on April 27 After-Market (BJT), actual revenue CNY 147.29 M, actual EPS CNY 0.059

TIBET AIM PHARM FY2026 Q1 Earnings Release on April 28 After-Market (BJT)

TIBET AIM PHARM to Release FY2025 Earnings on April 28 After-Market (BJT)

TIBET AIM PHARM released FY2025 Q3 earnings on October 28 Pre-Market (BJT), actual revenue CNY 177.54 M, actual EPS CNY 0.243

TIBET AIM PHARM released FY2025 9 Months Earnings on October 28 Pre-Market (BJT), actual revenue CNY 488.98 M, actual EPS CNY 0.443

TIBET AIM PHARM to Release FY2025 Q3 Earnings on October 29, Pre-Market BJT

TIBET AIM PHARM released FY2025 Semi-Annual earnings on August 14 After-Market (BJT), actual revenue CNY 311.45 M, actual EPS CNY 0.2

TIBET AIM PHARM released FY2025 Q2 earnings on August 14 After-Market BJT, actual revenue CNY 162.91 M, actual EPS CNY 0.1

TIBET AIM PHARM to Release FY2025 Semi-Annual Earnings on August 15, 2025 (BJT)

Yiming Pharmaceutical Director Zhou Zhan Reduced 1.68 million Shares

Aoyinbo Acquires 23% of Yiming Pharmaceutical for 662 Million Yuan

Second death linked to Elevidys therapy, trials paused

Yiming Pharmaceutical Director Zhou Zhan Reduced 1.848 Million Shares

Apoorv Yao Acquires Control of YiMing Pharmaceutical

Director of Yi Ming Medicine Reduced Shares

Yao Jinchao Acquires 23% of Yi Ming Medicine for 662 Million Yuan

Aphrodite Apollo Assumes Control of Yi Ming Pharmaceutical

Yiming Pharmaceutical Abnormal Stock Fluctuation and Share Transfer

MNDR

002826

Mobile-health Network Solutions (NASDAQ:MNDR) shares surged 21.30% on Wednesday following a non-binding $119 million MOU with Hector Capital Holdings aimed at acquiring BIMA and M&M Helix to expand its AI-powered healthcare services in Asia and Africa. The deal is contingent on due diligence and regulatory approvals. The broader market also supported this rise, with the Nasdaq up 1.23% and the S&P 500 up 0.81%. MNDR operates the MaNaDr platform, focusing on telemedicine and related services, primarily generating revenue from Singapore.

benzinga_article

Mobile-Health Network Solutions

iShares Global Healthcare

SPDR S&P Biotech

E Fund CSI Biotechnology Theme ETF

Minsheng Royal CSI Biotechnology Theme ETF

Proshares Ultra Nasdaq Biotech

China Merchants CSI Biotechnology Theme ETF

ChinaAMC CSI Biotechnology Theme ETF

E Fund CSI 300 Health Care ETF

iShares Biotechnology ETF

China Universal 800 Health Care ETF

Dacheng CSI All Share Health Care Equipment and Services ETF

iShares US Healthcare Providers

SPDR S&P Health

First Trust NYSE Arca Biotech Index Fd

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Guotai SSE STAR Brand Name Drug ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

ALPS Medical Breakthrough

VG Health

VanEck Biotech ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Nasdaq

NASDAQ Composite Index

S&P 500

Why Is Mobile-health Network Stock Soaring Wednesday?

President Trump has signed a proclamation to accelerate the onshoring of pharmaceutical manufacturing, addressing America's vulnerability in the sector. Currently, over half of branded pharmaceuticals are made overseas, with only 11% of active ingredients produced in the U.S. The proclamation imposes a 100% tariff on patented pharmaceuticals but offers reduced tariffs for companies committing to onshoring. It aims to rebuild domestic capacity and improve national resilience, emphasizing that economic security is national security. The initiative also includes favorable tariff treatment for key allies and aims to enhance quality control in pharmaceuticals.

Thehill

America’s medicine cabinet must come home

ONEQ

The healthcare sector has emerged as a reliable source of job growth in the US, adding 76,000 jobs in March alone, according to the Bureau of Labor Statistics. This growth is driven by an aging population and rising chronic illnesses, with healthcare consistently adding jobs since January 2022. However, challenges such as rising costs and potential policy changes may threaten this stability. Experts warn that financial pressures could lead to workforce reductions and consolidation within the industry, despite the ongoing demand for healthcare services.

Invezz

Fidelity Nasdaq Composite Index ETF

How healthcare became the most reliable source of paychecks in the US

Oman is set to enhance its healthcare services in alignment with Vision 2040, marking World Health Day on April 7. The Ministry of Health aims to improve service quality through technological advancements, including precision medicine and AI. Initiatives like teleradiology and virtual consultations have already been implemented, with plans for further services such as tele-ICU and tele-stroke management. The focus is on creating an integrated health system that leverages digital solutions to provide accessible, high-quality care, while also preparing for the 11th Five-Year Plan (2026–2030).

Zawya

ZAWYA: Oman aims for tech-driven healthcare services in line with Vision 2040 goals

.IXIC

002820

Pharmacy benefit managers (PBMs) are facing increased scrutiny and regulatory changes due to potential conflicts of interest and opaque revenue sources. The 2026 Consolidated Appropriations Act mandates that PBMs pass through 100% of rebates to employer health plans, altering their revenue streams and incentives. As a result, PBMs may intensify formulary management tactics and demand flat fees from drugmakers for access. This shift could lead to new opportunities for manufacturers as PBMs adapt their strategies in response to heightened transparency and scrutiny.

- Pharmacy benefit managers (PBMs) play a crucial role in the pharmaceutical ecosystem but face increasing scrutiny due to conflicts of interest and opaque revenue sources.  
- The 2026 Consolidated Appropriations Act mandates PBMs to pass 100% of rebates to employers and increases transparency around pricing and drug access, altering PBM revenue streams and market dynamics.  
- As a result, manufacturers must adapt their strategies, focusing on predictability and direct negotiating tactics to thrive in a transformed landscape where traditional rebate models are reshaped.

Pharmexec

Guifaxiang

Invesco QQQ Trust

Proshares UltraPro QQQ

CHENGDU RAINBOW APPLIANCE(GROUP)SHARERS

ProShares Ultra QQQ

Redwall

Dow Jones Industrial Average

<![CDATA[New Federal Market Access Restrictions: Optimizing Manufacturer Strategies as PBMs Gain Power]]>

Healthcare continued to drive gains in employment, while better weather in March also helped.

Breaking down the booming March jobs report

GBTC

ABTC

The US economy added 178,000 jobs in March, significantly exceeding expectations of 59,000, while the unemployment rate fell to 4.3%. This strong job growth, primarily driven by healthcare and social assistance, may influence the Federal Reserve's decision on interest rates. Bitcoin dropped 0.5% to $66,500 following the news, reflecting reduced expectations for rate cuts. Overall, the labor market shows signs of strength, but concerns remain about the sustainability of this growth amid a deceleration in job creation averages.

- The US economy added 178,000 jobs in March, significantly exceeding Wall Street's forecast of 59,000, while the unemployment rate fell to 4.3%.  
- This job growth, primarily driven by healthcare and social assistance, suggests the Federal Reserve may maintain current interest rates, though the six-month average indicates a slowdown in job creation.  
- Bitcoin dropped 0.5% to $66,500 in reaction to the robust jobs report, reflecting reduced expectations for rate cuts, while stock markets remained closed for Good Friday.

TradingView

Grayscale Bitcoin Trust BTC - ETF

Grayscale Bitcoin Mini Trust ETF

American Bitcoin

Coinbase

Bitwise Bitcoin ETF

VanEck Bitcoin ETF

Franklin Bitcoin ETF

ARK 21Shares Bitcoin ETF

Invesco Galaxy Bitcoin ETF

iShares Bitcoin Trust ETF

Fidelity Wise Origin Bitcoin Fund - ETF

ProShares Bitcoin Strategy ETF

WisdomTree Bitcoin Fund

Grayscale Bitcoin Adopters ETF

CoinShares Bitcoin ETF

US NFP: Job Growth Explodes with 178,000 March Hires, Far Above Estimates

The U.S. Bureau of Labor Statistics announced that non-farm payrolls increased by 178,000 in March, far exceeding market expectations of 60,000, marking the highest increase since December 2024. The new jobs were mainly concentrated in industries such as healthcare (76,000), construction (26,000), and transportation and warehousing (21,000). The unemployment rate slightly decreased to 4.3%

AASTOCKS

"Economics" In March, the United States added 178,000 non-farm jobs, far exceeding expectations, and the unemployment rate fell to 4.3%

U.S. employment growth surged in March, with non-farm payrolls increasing by 178,000 jobs, surpassing expectations of 60,000. The unemployment rate fell to 4.3%, despite concerns over potential conflict with Iran. The rebound was attributed to the resolution of a healthcare strike and improved weather conditions. Wage growth was driven by gains in the healthcare sector, while construction, leisure, and hospitality also saw recoveries. However, rising energy prices due to Middle East tensions may pose inflation risks, influencing the Federal Reserve's focus on economic stability.

CoinLive

U.S. Employment Surges in March Amid Healthcare Strike Resolution

TIBET AIM PHARM(002826.SZ)